GlassScriptPhysician profile
Michael Patrick Harlander-Locke
NPI 1689231524
$15,631.92
in general payments reported to CMS, 2019-2025
16 companies · $3,497 in 2025
The $3,497 reported for 2025 was more than what 90% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $15.85 · 2022: $94.77 · 2023: $11K · 2024: $831 · 2025: $3,497.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $10K · Travel and Lodging: $2,872 · Food and Beverage: $2,649.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $10,000.00 |
| Travel and Lodging | $2,872.30 |
| Food and Beverage | $2,649.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $10,656.60 | 2023-2025 | Wavewriter Alpha Prime 16, Intracept |
| Medtronic, INC. | $2,499.61 | 2022-2025 | Synchromedii, Intellis Adaptivestim, Vanta Adaptivestim |
| Abbott Laboratories | $1,461.22 | 2025 | Proclaim, Eterna |
| Spr Therapeutics, INC | $246.72 | 2023-2024 | Sprint Pns System |
| Bioventus LLC | $136.29 | 2023 | Stimrouter Implantable Kit |
| Merz Pharmaceuticals, LLC | $113.79 | 2025 | Xeomin |
| Getinge USA Sales, LLC | $111.49 | 2020-2025 | Cardiohelp, Cardiosave Rescue |
| Abbvie INC. | $84.91 | 2023 | |
| Tersera Therapeutics LLC | $80.49 | 2025 | Prialt |
| Vertex Pharmaceuticals Incorporated | $64.98 | 2025 | |
| Saluda Medical Americas, INC. | $57.99 | 2025 | Evoke |
| Globus Medical, INC. | $35.44 | 2025 | Senza |
| Fisher & Paykel Healthcare INC | $23.68 | 2023 | Fisher & Paykel Healthcare |
| Draeger Medical Systems, INC | $22.00 | 2022 | |
| Ibsa Pharma INC. | $20.02 | 2025 | Licart, Tirosint, Flector |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Pfizer INC. | $16.69 | 2024 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Harlander-Locke listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.